Dundee Corporation
Dundee Corporation is a publicly owned investment manager based in Toronto, Canada, with an additional office in Vancouver. Established in 1984, the corporation engages in various business activities through its subsidiaries, including investment advisory, corporate finance, energy, resources, agriculture, real estate, and infrastructure. It manages a diverse portfolio of investments, comprising both publicly listed and private enterprises, and strategically invests its own capital alongside that of its clients and partners. With a workforce of over 1,500 employees worldwide, Dundee Corporation focuses on sectors with significant potential to create value for its clients and shareholders.
Ausgold Limited is a gold exploration and development company based in Perth, Australia, established in 2009. The company's primary focus is the Katanning Gold Project, situated in the Katanning greenstone belt in south-western Western Australia, covering approximately 4,000 square kilometers. In addition to its flagship project, Ausgold explores for various other minerals, including copper, iron, nickel, and sulphide deposits across its suite of projects, which also includes the Cracow Project and the Yamarna Project.
Sweet Natural Trading Co. Limited produces and packages natural sweetener products. It offers coconut sugar, xylitol, lollipops, honey, bread, butter, flour, oats, chocolate bars, soda, tea, and fruit drops. The company’s products are sold in approximately 7,000 stores; and to distributors. It also sells its products through sweetnaturaltrading.com. The company was formerly known as Xylitol Canada Inc. and changed its name to Sweet Natural Trading Co. Limited in December 2017. Sweet Natural Trading Co. Limited was founded in 2004 and is headquartered in North York, Canada.
Tribute Pharmaceuticals is a Canadian specialty pharmaceutical company engaged in the acquisition, licensing, development and management of pharmaceutical and healthcare products with its primary focus on the Canadian market. Tribute Pharmaceuticals has two facilities located in Milton, Ontario and London, Ontario and takes great pride in its employees, sales representatives and authorized third parties providers. Our mission is to offer quality healthcare products that treat recognized medical conditions and diseases. Tribute is committed to providing patients and physicians with clinically proven pharmaceuticals products that have been approved by regulatory authorities in Canada and other parts of the world.
Private Equity Round in 2013
Eagle Hill Exploration Corporation, a mineral exploration company, engages in the exploration and development of mineral properties in Canada. It focuses on the Windfall Lake gold deposit comprising 285 contiguous mineral claims covering an area of 12,400 hectares and is located in the Abitibi Gold Belt in Quebec. The company was founded in 2006 and is headquartered in Vancouver, Canada. As of August 25, 2015, Eagle Hill Exploration Corporation operates as a subsidiary of Oban Mining Corporation.
Private Equity Round in 2013
TauRx Pharmaceuticals, founded in Singapore in 2002, focuses on developing treatments and diagnostics for neurodegenerative diseases by targeting aggregates of Tau protein within nerve cells. The company's research has identified LMTX™, which shows potential benefits not only for Alzheimer's disease but also for other conditions linked to Tau pathology, such as Parkinson's, Huntington's disease, and Frontotemporal Dementia. TauRx operates its primary research facilities in Aberdeen, Scotland, and is dedicated to the discovery, development, and commercialization of innovative products, guiding them from preclinical stages through clinical trials and regulatory approvals. The overarching goal is to provide solutions that may help halt the progression of various neurodegenerative diseases caused by protein aggregation.